Accepted at 5:02 a.m. Aug, 06, 2025 by Ahmed7
Author: Jwill
Related Note: 1485382286527 1
Rationale for change

QID currently not tagged, pt recently started donepezil for alzheimer and is now experiencing urinary incontinence and daughter is requesting oxybutynin bc it helps her and believes it will help the pt too.
Answer: discontinue donepezil

Explains its an AE, AMBOSS agrees

https://next.amboss.com/us/article/HN0Kcg?utm_campaign=EN_XX_Browser-Extension-Chrome&utm_medium=browser_extension&utm_source=apps.uworld.com&utm_term=Indirect_parasympathomimetics&browser-extension-target=new-tab#Zfcc1b3ac70ea52f1a0512fde00957f7b
Source: UWorld - Step 2 109145

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step2_v12::#UWorld::Step::109145
#AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#B&B::16_Neuro::04_Autonomic_Nervous_System::03_ANS_Drugs:_Acetylcholine #AK_Step1_v12::#UWorld::Step::1442 #AK_Step2_v12::#AMBOSS::rn0fug #AK_Step1_v12::#OME_banner #AK_Step1_v12::#UWorld::Step::18497 #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::FA-Neuro #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::08_Dementia #AK_Step2_v12::#AMBOSS::an0Q7g #AK_Step1_v12::#AMBOSS::p2aLiP #AK_Step1_v12::#B&B::16_Neuro::04_Autonomic_Nervous_System::06_Cholinergic_Drugs #AK_Step2_v12::#CMS::Psychiatry::Form_6 #AK_Step1_v12::#NBME::21 #AK_Step2_v12::#B&B::10_Neuro::05_OtherTopics::06_Dementia #AK_Step1_v12::#AMBOSS::WhaP14 #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::07_Cholinomimetic_agents::*Indirect_Agonists::Alzheimers_Therapy #AK_Step1_v12::#UWorld::COMLEX::26658 #AK_Step1_v12::#UWorld::COMLEX::26659 #AK_Step1_v12::#UWorld::COMLEX::24553 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#SketchyNeurology::04_Movement_&_Neurodegenerative_Disorders::01_Dementia::01_Dementias_DDx #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step2_v12::#SketchyNeurology::04_Movement_&_Neurodegenerative_Disorders::01_Dementia::02_Alzheimer_Disease #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::08_Neurodegenerative_disease_therapy::*Alzheimers::Acetylcholinesterase_Inhibitor #AK_Step2_v12::#AMBOSS::sn0tug #AK_Step1_v12::#Physeo::09_Pharm::16_Autonomic_Pharm::10_Indirect_Cholinergic_Agonists #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::13_Alzheimer_Disease_Treatment_(Donepezil,_Rivastigmine,_Galantamine,_Memantine) #PANCE::EOR::Family_med #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::09_Alzheimer's_Medications::01_Alzheimer's_Disease_Medications #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::07_Cholinomimetics_-_Anticholinesterases #AK_Step1_v12::#UWorld::Step::18498 #AK_Step1_v12::#Bootcamp::Neurology::26_Dementia::01_Alzheimer_Dementia #AK_Step1_v12::#NBME::26 #AK_Step1_v12::#Pixorize::03_Pharmacology::02_Cholinomimetics::05_Donepezil_Rivastigmine_&_Galantamine